1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6A82BA3055154E45285256C63005B557A
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/strategies-for-broad-based-pharmaceutical-branding?opendocument
18
19opendocument
2034.228.38.35
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Brand Management and Product Leadership Branding and Identity

Executive Summary: Strategies for Broad-Based Pharmaceutical Branding

DB Image

ID: 4307


Features:

Graphics


Words: 2,677


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
According to Food and Drug Administration (FDA) statistics, about two thirds of all new products launched in the pharmaceutical marketplace in the past 11 years grew from existing molecular entities. This 8-page document summarizes key findings on effectively implementing this common practice for pharmaceutical marketing and brand team executives. The insights, gleaned from interviews with six leading pharmaceutical companies and personnel from the FDA, cover some of the essential elements of broad-based branding and trademark decision-making, including

Setting Lifecycle Management Directions Early

Understanding Customer Segments and Key Marketing Factors

Evaluating Synergies and Conflicts Across Indications

Addressing Regulatory Concerns Around Multiple Brands

Industries Profiled:
Market Research; Manufacturing; Medical Device; Pharmaceutical; Financial Services; Service; Retail; Research; Computer Software; Diagnostic; Health Care; Transportation; Biotech; Clinical Research; Consulting; Distribution; Insurance; Hospitality; Telecommunications; Technology; Professional Services; High Tech; Automobile; Utilities; Energy; Consumer Products; Chemical; Medical; Electronics; Laboratories; Biopharmaceutical; Banking; Computers; Entertainment; Internet; Computer Hardware; Aerospace; Academic; Media; Education; Newspapers; Government; Shipping; Science; Office Supplies; Marketing; Office Equipment; Cable; Advertising; Defense; Military; Diversified; Sports; Technology; Public Relations; Multiple; Communications; Logistics; Publishing; Real Estate; Construction; Architecture; Engineering; Aviation; Legal; Test Industry; Non-Profit; Business; Orthopaedics


Companies Profiled:

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.